Opal Wealth Advisors’s Alpha Tau Medical DRTS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$149K Hold
10,000
– – 0.03% 213
2026
Q2
$126K Hold
10,000
– – 0.03% 216
2026
Q1
$70.7K Hold
10,000
– – 0.02% 338
2025
Q4
$49.5K Hold
10,000
– – 0.01% 205
2025
Q3
$45.1K Hold
10,000
– – 0.01% 194
2025
Q2
$31.2K Hold
10,000
– – 0.01% 463
2025
Q1
$25.1K Hold
10,000
– – 0.01% 482
2024
Q4
$31K Hold
10,000
– – 0.01% 191
2024
Q3
$23.8K Hold
10,000
– – 0.01% 189
2024
Q2
$25.3K Hold
10,000
– – 0.01% 453
2024
Q1
$29.5K Hold
10,000
– – 0.01% 225
2023
Q4
$30.1K Hold
10,000
– – 0.01% 170
2023
Q3
$37.9K Hold
10,000
– – 0.02% 142
2023
Q2
$43.7K Hold
10,000
– – 0.02% 145
2023
Q1
$28.7K Hold
10,000
– – 0.02% 114
2022
Q4
$31.8K Buy
+10,000
New +$41.4K 0.02% 125

Other funds holding DRTS

Opal Wealth Advisors's DRTS Position: Q3 2026 in Review

Opal Wealth Advisors held its Alpha Tau Medical (DRTS) position steady in Q3 2026 at 10,000 shares worth $149K. The position accounts for 0.03% of the portfolio, ranked #213.

Opal Wealth Advisors first reported a position in DRTS in Q4 2022 and has held it in 16 quarters since. 11 funds tracked by Wall St. Rank hold DRTS as of Q3 2026.

  • Opal Wealth Advisors held 10,000 shares of Alpha Tau Medical worth $149K as of Q3 2026.
  • Opal Wealth Advisors left its Alpha Tau Medical share count unchanged in Q3 2026.
  • Alpha Tau Medical made up 0.03% of Opal Wealth Advisors's portfolio in Q3 2026, its #213 holding.
  • Opal Wealth Advisors first reported a position in Alpha Tau Medical in Q4 2022 and has held it in 16 quarters since.
  • 11 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q3 2026.

Based on Opal Wealth Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.